Loading…
Yes. One or two interval sessions weekly. VO₂ max sits in the top quartile of all-cause mortality predictors.
VO₂ max is among the strongest mortality predictors we measure; intervals raise it faster than steady-state alone.
Our read is Well Supported. The intervention clears a strong evidence base (86/100) with broad agreement among the voices we track (92% consensus). At $0/month and medium effort, training VO₂ max with intervals is one of the more defensible moves on this list — the burden of proof has largely been met.
Pulled the public claims about training VO₂ max with intervals from proponents on file (a tracked voice and a tracked voice) and weighed them against the more cautious voices in the field, then cross-checked each against the primary trial and cohort literature and the prevailing clinical guidance. We grade the claim against what the human evidence actually supports, not against how confidently it is stated.
Downside risk on training VO₂ max with intervals is low at sensible doses, but low risk is not no risk: individual response varies, and a low-risk intervention is still only worth it if the benefit is real.
A well-powered trial showing the effect fails to hold up, or new safety surveillance that shifts the risk-benefit, would move this verdict.
The effect size is large enough to matter clinically, not just statistically.
The intervention improves the primary outcome at standard doses in healthy adults.
Mechanistic and trial evidence converge on a real, replicable effect.
Benefits hold across the populations where it's been tested.
The effect size is large enough to matter clinically, not just statistically.
Animal-model results don't translate to the human protocol being recommended.
Most of the support comes from short or small studies.
Confounding and publication bias inflate the apparent benefit.
Most of the support comes from short or small studies.